25 - 26 September 2023, Zurich, Switzerland.Their report, appearing in the July 12 issue of Science Robotics, maps some of the ethical considerations for governments, policy makers, technologists, and clinicians, and urges stakeholders to come together to rapidly develop guidelines for trust, agency, engagement, and real-world efficacy.
Opinion Article by Mark Venables, Chief Executive, Highland Marketing.Knowing a tumor's molecular type enables neurosurgeons to make decisions such as how much brain tissue to remove and whether to place tumor-killing drugs directly into the brain - while the patient is still on the operating table.
The study by researchers at New York University, Columbia Engineering, and the New York Genome Center, combines a deep learning model with CRISPR screens to control the expression of human genes in different ways - such as flicking a light switch to shut them off completely or by using a dimmer knob to partially turn down their activity.
NHS technology provider C2-Ai has been recognised at four high-profile UK healthcare and technology awards on a single night, after surgical teams across dozens of hospitals delivered significant impact for patients on waiting lists.
Surgeons say they are revolutionising how NHS waiting lists are managed with the help of the UK company’s technology, which is providing staff with an unprecedented understanding of the risks facing every individual patient.